PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma

NCT02892695 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Mantle Cell Lymphoma
B-cell Prolymphocytic Leukemia
Diffuse Large Cell Lymphoma

Interventions

BIOLOGICAL: anti-CD19 CAR-NK cells

Sponsor

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Collaborators

[object Object]
[object Object]